What Aqua Pharma does

Aqua Pharma AS is a Norwegian aquaculture veterinary services company founded in 2009 and headquartered in Lillehammer, operating as the Aqua Pharma Group joint venture between Solvay (Belgian specialty chemicals leader) and Aquatiq (Norwegian food safety reference). The company provides products, equipment, and services for the prevention and control of disease in salmon and shrimp farming, with hydrogen peroxide (H2O2) bath treatments — marketed as Paramove® — at the core of the portfolio. Its proprietary dosing equipment suite (Types N, C, S, and W containers) supports tarpaulin and well-boat treatment methods, with over 30 dosing systems installed globally and operations across nine countries including Norway, Scotland, Chile, Canada, the USA, Australia, Belgium, Ecuador, and Indonesia.

The technical platform combines veterinary-grade H2O2 chemistry with purpose-built mechanical dosing and, following the 50% Pulcea stake (May 2020), emerging acoustic-assisted treatment technology under the BREEZE initiative. Aqua Pharma has expanded from salmon into shrimp via the SEATRU™ microbial-control service platform (launched June 2022 in partnership with KYTOS and eFishery), and has obtained regulatory and sustainability validations including veterinary medicine registration, the Solar Impulse Foundation's Efficient Solutions Label (2019), and Aquaculture Stewardship Council supporter status.

The business model is built on two revenue streams: product sales of H2O2-based veterinary medicines and hardware sales of dosing equipment systems, complemented by recurring technical services, inspections, and bespoke engineering. Pricing is quote-based, sold through a direct enterprise field-sales motion via regional managers, with manufacturing executed through the Aquatiq Hygiene Systems partnership in Norway and Scotland. The customer base is concentrated in salmon farming geographies, with project-level relationships including Scottish Sea Farms (BREEZE host) and eFishery (SEATRU Indonesia). The company employs approximately 50 people globally and does not disclose revenue.

Name

Aqua Pharma

Legal name

Aqua Pharma AS

Website

https://aqua-pharma.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Aqua Pharma is a Norwegian aquaculture veterinary services provider, jointly owned by Solvay and Aquatiq, that sells hydrogen peroxide bath treatments (Paramove®) and proprietary dosing equipment for sea lice and disease control in salmon and shrimp farms across nine countries.

Ownership category

akta.pro rank

Product category

Aquaculture Veterinary Health Products and Equipment

NAICS

Veterinary Services (54194), Finfish Farming and Fish Hatcheries (112511)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Aquaculture Health, Biosecurity & Veterinary Services (AFAEAAAK)

akta.pro secondary industries

Aquaculture & Fish Health Services (AFAEANAE), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Aquaculture veterinary services
• Hydrogen peroxide treatment
• Sea lice control
• Dosing equipment systems
• Water conditioning solutions

Headquarters

HQ city

Lillehammer

HQ country

Norway

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Hydrogen Peroxide Treatment Products: Sale of H2O2 based veterinary medicines for sea lice and disease treatment in salmon and shrimp farms. Products include Paramove and Food Grade H2O2 for shrimp applications.
2. Dosing Equipment Sales and Servicing: Design, manufacture, and sale of dosing equipment systems (Type N, C, S, W containers). Also provides regular inspections, treatment-related technical services, and bespoke engineering for maritime installations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Aqua Pharma develops, manufactures, and supplies hydrogen peroxide-based veterinary medicines (Paramove®) together with proprietary dosing equipment for bath treatments used in salmon and shrimp aquaculture. Its portfolio supports sea lice and ectoparasite control, Amoebic Gill Disease management, and water conditioning/oxygenation for shrimp ponds, complemented by technical dosing services and emerging platforms such as SEATRU™ and BREEZE.

Product overview

Aqua Pharma is a veterinary services provider for aquaculture offering a unified portfolio of disease prevention and control products and equipment for salmon and shrimp farming. The core offering centers on Paramove® hydrogen peroxide bath treatments (available as tarpaulin or well boat applications) for sea lice and parasite control. Supporting the core treatment products is a family of four specialized dosing equipment systems (Types N, C, S, W containers) for precise H₂O₂ delivery, along with associated technical services. For shrimp farming, the company provides water conditioning and oxygenation solutions, underpinned by the SEATRU™ microbial control service platform. The company also has emerging technology in development through the BREEZE consortium, combining acoustic technology with hydrogen peroxide treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Paramove® Bath Treatment Registered hydrogen peroxide veterinary medicine for rapid removal of sea lice and other ectoparasites in salmon farms; decomposes into water and oxygen with zero residue post-treatment. Sold to commercial salmon farming operators and applied via tarpaulin or well-boat delivery.
• Tarpaulin Treatment In-pen bath treatment service using Paramove® H2O2 within a contained tarpaulin, minimizing fish handling and stress for salmon farms.
• Well Boat Treatment Bath treatment service delivered via well boat equipped with closed dosing systems, delivering precise treatment volumes for salmon parasite control with high safety standards.
• Water Conditioning & Oxygenation (Shrimp) Eco-friendly Food Grade hydrogen peroxide water conditioning and preventative oxygenation products designed to maintain water quality and prevent health issues in shrimp ponds.
• SEATRU™ Service Platform Service platform for shrimp farmers offering microbial control through precise dosing recommendations, combining sanitisers, oxygen aids, and bioremediation supported by KYTOS microbial fingerprinting technology.
• Dosing Equipment Systems (Types N, C, S, W) Proprietary dosing containers (Type N high-capacity, Type C semi-automated, Type S flagship, Type W well-boat specific) for accurate delivery of pharmaceutical-grade 50% hydrogen peroxide; over 30 dosing systems installed globally.
• Dosing Services Technical services including regular inspections, treatment-related technical support, and bespoke engineering for maritime installations of dosing systems.
• BREEZE Anti-Sea Lice Treatment Anti-sea lice treatment concept combining hydrogen peroxide bath treatment with Pulcea's acoustic technology; EIT Food-funded initiative aimed at more effective, less stressful sea lice removal.

Quantifiable outcome

• H2O2 concentrations in aquaculture treatment are 0.08% or 0.02% vs 3% for wound disinfection and 6% for dental applications
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered minor, core and flagship.

• Scottish Sea FarmsminorStrategic or Co-development Partner · 1 October 2022Host partner for BREEZE anti-sea lice treatment trials at their Shetland salmon farm. October 2022 trials validated environmental safety of sonic technology in open marine environment.
• KYTOScoreStrategic or Co-development Partner · 1 June 2022Microbial fingerprinting experts collaborating on SEATRU research project to develop shrimp health management platform using precise dosing recommendations.
• eFisherycoreStrategic or Co-development Partner · 1 June 2022World's largest aquaculture tech start-up serving as local partner for SEATRU research project in Indonesia. The initiative kicked off July 2022 with a two-year research project.
• EIT FoodcoreStrategic or Co-development Partner · 1 January 2021European consortium funding the BREEZE initiative (EITFood funded). BREEZE project selected for EIT Food 2021 Business Plan for Sustainable Aquaculture.
• Norwegian University of Science & Technology (NTNU)minorStrategic or Co-development Partner · 1 January 2021BREEZE consortium partner contributing academic research expertise to the sustainable aquaculture initiative.
• PulceacoreStrategic or Co-development Partner · 1 May 2020Aqua Pharma took 50% stake in Pulcea under a six-figure deal. Pulcea developed sound energy technology to improve efficiency of sea lice treatments. Acoustic power causes oxygen bubbles from H2O2 breakdown to oscillate, causing more damage to lice while being less stressful for fish.
• SolvayflagshipStrategic or Co-development Partner · 1 September 2019Joint venture between Solvay and Aquatiq created Aqua Pharma Group in September 2019. Solvay provides deep expertise in hydrogen peroxide technology (Paramove product) while Aqua Pharma offers state-of-the-art dosing equipment. The partnership aims to become a key aquaculture player offering sustainable solutions for sea lice control and Amoebic Gill Disease (AGD).
• AquatiqflagshipStrategic or Co-development Partner · 1 September 2019Joint venture partner providing Norwegian food safety expertise. Aquatiq brings expertise in food hygiene and safety to the partnership, establishing Aqua Pharma's foundation in disease prevention and control systems for salmon farming.
• Aquatiq Hygiene SystemscoreImplementation/ SI/ Consulting PartnerManufacturing partner for final dosing equipment designs. Manufactures dosing equipment at facilities in Lillehammer, Norway and Oban, Scotland.
• AQS (Aquaculture Quality Systems)coreChannel Partner/ Reseller/ DistributorNorwegian partner providing bath treatment services. Aqua Pharma partnership with AQS covers treatment delivery in Norway.

Scale indicators3 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Pharmaq (Zoetis): Pharmaq, now part of Zoetis, is a leading animal health company specialising in aquaculture vaccines and pharmaceuticals for salmon and other farmed fish. Direct overlap with Aqua Pharma's veterinary medicine portfolio for salmon and shrimp disease control.
• Benchmark Animal Health: Benchmark Holdings operates in aquaculture genetics and animal health, providing specialist health products and breeding services for salmon and shrimp. Comparable as a vertically integrated aquaculture health specialist with proprietary IP.

Broad incumbents

• MSD Animal Health (Intervet): MSD Animal Health, the veterinary division of Merck, offers a broad portfolio including aquaculture vaccines and pharmaceuticals. Competes with Aqua Pharma across the salmon and shrimp health categories as a much larger incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aqua-pharma
• Xx.com/aquapharmaltd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aqua Pharma